Sanai Health Industry Group Company Limited provided earnings guidance for the year ended 31 December 2022. For the year, the Group is expected to record (i) a revenue of approximately RMB 175.92 million for the year ended 31 December 2022 (the "Period''), representing an increase of approximately 160.2% as compared with the year ended 31 December 2021; and (ii) a profit attributable to owners of the Company of approximately RMB 29.22 million for the Period, representing an increase of approximately 223.6% as compared with the year ended 31 December 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.027 HKD | 0.00% | 0.00% | -57.81% |
1st Jan change | Capi. | |
---|---|---|
-57.81% | 13.2M | |
+32.85% | 698B | |
+26.51% | 568B | |
-4.57% | 358B | |
+19.34% | 328B | |
+3.61% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.78% | 165B |
- Stock Market
- Equities
- 1889 Stock
- News Sanai Health Industry Group Company Limited
- Sanai Health Industry Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2022